zatvoriť galériu
WA 38 Amsterdam - Na snímke budova Európskej agentúry pre lieky (EMA) v Amsterdame v utorok 20. apríla 2021. FOTO TASR/AP Exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, Tuesday, April 20, 2021. Experts at the European Medicines Agency are preparing to present the conclusions of their investigation later on Tuesday into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected
Späť na článok

EMA začala s hodnotením lieku od GlaxoSmithKline

WA 38 Amsterdam - Na snímke budova Európskej agentúry pre lieky (EMA) v Amsterdame v utorok 20. apríla 2021. FOTO TASR/AP Exterior view of the European Medicines Agency, EMA, in Amsterdam's business district, Netherlands, Tuesday, April 20, 2021. Experts at the European Medicines Agency are preparing to present the conclusions of their investigation later on Tuesday into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected Zdroj: Peter Dejong